Official Title
Decoding the Genetic Landscape of Skeletal Diseases
Brief Title
Decoding the Genetic Landscape of Skeletal Diseases
Protocol ID
NCT05876416
Lead Sponsor
Karolinska Institutet
Brief Summary
This 5-year project aims to (1) search for genetic causes for yet unsolved congenital
skeletal disorders (GSDs); (2) study consequences of the newly identified pathogenic
variants in cells and in transgenic mice, (3) summarize data on natural course and
complications for different GSD groups. For patients with unsolved GSD, the investigators
search for molecular causes of GSDs using whole genome sequencing (WGS) and total
ribonucleic acid (RNA) sequencing. Candidate gene variants are selected using genome or
transcriptome sequencing data, clinical findings and screening of omics databases.
Causality of the new variants is studied in cells and in transgenic mice models.
Molecular and clinical findings are summarized for different GSD groups.
Detailed Description
Genetic skeletal disorders (GSDs) are a large group of rare diseases caused by
abnormalities in genes regulating skeletal development. This 5-year project aims to (1)
search for genetic causes for yet unsolved congenital skeletal disorders; (2) study
consequences of the newly identified pathogenic variants in cells and in transgenic mice,
(3) summarize data on natural course and complications for different GSD groups. The
project is a collaboration between the Dept of Clinical Genetics, Karolinska University
Hospital, Lab of Clinical Genetics and Lab of Bone and Cartilage Physiology, Karolinska
Institutet and Sahlgrenska Academy. In a well-characterized group of 300 GSD participants
whose DNA samples were analyzed using whole genome sequencing (WGS), there are 120 study
participants with unsolved diagnoses. For those participants, we search for molecular
causes of GSDs using WGS and total RNA sequencing. Candidate gene variants are selected
using genome or transcriptome sequencing data, clinical findings and screening of omics
databases. Causality of the new variants is studied in cells and in transgenic mice
models. Molecular and clinical findings are summarized for different GSD groups. Our
results improve diagnostics for GSDs, advance knowledge on pathogenesis and help
establishing new individual follow-up and treatment strategies for patients with GSDs.
This project increases understanding of skeletal pathophysiology and will contribute to
the development of novel treatment methods for skeletal diseases.
Study Period
-
Enrollment Count
450 participants
Eligibility Criteria
Inclusion Criteria:
Clinically suspected skeletal dysplasia based on previous investigations
Abnormal height
Radiographic abnormalities of the skeleton in addition to other syndromic features
Healthy relatives of the affected study participants
Exclusion Criteria:
No radiographic data available from clinical investigations
Suspected environmental or multifactorial causes
Filters
Genetic Skeletal Diseases
Skeletal Dysplasia
Molecular Causes
Skeletal Disorder
RECRUITING
CHILD
ADULT
OLDER_ADULT